Skip to content
Screener

McKesson MCK Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
500K0.0%
Medline, Inc. logo
Medline, Inc.MDLN
$5B
Doximity logo
DoximityDOCS
$100M0.0%
Merck & Co. logo
Merck & Co.MRK
$20M0.0%
Omnicell logo
OmnicellOMCL
$5M0.0%
TOI
TOITOI

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$102.58B+22.6%
Enterprise value$110.3B+19.6%
P/E22.3×-4.1×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
Line itemJune 30, 2026March 31, 2026
Other non-current liabilities2,7422,659
Redeemable noncontrolling interests2,563943
McKesson Corporation stockholders’ deficit
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding
Common stock, $0.01 par value, 800 shares authorized, 280 shares issued at June 30, 2026 and March 31, 202633
Additional paid-in capital8,5888,284
Retained earnings22,80822,291
Accumulated other comprehensive loss(749)(745)

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's preferred stock, shares authorized?
McKesson (MCK) reported preferred stock, shares authorized of $100M in Q2 2026.
How has McKesson's preferred stock, shares authorized changed year-over-year?
McKesson's preferred stock, shares authorized decreased by 0.0% year-over-year, from $100M to $100M.
What is the long-term trend for McKesson's preferred stock, shares authorized?
Over 5 years (2021 to 2026), McKesson's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $100M to $100M.
What does preferred stock, shares authorized mean?
Preferred Stock, Shares Authorized

Ask your AI about McKesson's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude